NEW YORK, Nov. 9, 2006 (PRIMEZONE) -- Advanced Plant Pharmaceuticals Inc. (OTCBB:APPI) today announces signing a Memorandum of Understanding ("MOU") to acquire the Biodiesel company, World Health Energy, Inc. World Health Energy, Inc. ("WHE") is an emerging energy company focusing on biofuels and renewable energy production and distribution.
Biodiesel refers to a diesel-equivalent, processed fuel derived from biological sources. Though derived from biological sources, it is a processed fuel that can be readily used in diesel-engined vehicles, which distinguishes biodiesel from the straight vegetable oils or waste vegetable oils used as fuels in some modified diesel vehicles. Biodiesel is biodegradable and non-toxic, and has significantly fewer emissions than petroleum-based diesel when burned. Biodiesel functions in current diesel engines, and could in theory supplement fossil fuels as the world's primary transport energy source. Biodiesel reduces emissions of carbon monoxide (CO) by approximately 50% and carbon dioxide by 78% on a net lifecycle basis.
Biodiesel can also be used as a heating fuel in domestic and commercial boilers. Biodiesel can be distributed using today's infrastructure, and its use and production are increasing rapidly. Fuel stations are beginning to make biodiesel available to consumers, and a growing number of transport fleets use it as an additive in their fuel.
World Health Energy, Inc. plans to use renewable, cost-effective agricultural products from around the world to develop natural alternative fuels and marketable agricultural by-products such as feedstock. WHE's proposed Biodiesel production plant is designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214 as well as ASTM D6751 specifications.
In addition to renewable energy production, WHE's unique process will create a newly engineered feedstock as a by-product of the biodiesel production. Due to a feedstock shortages worldwide, the company plans to sell the feedstock as a secondary source of revenue, capitalizing on all aspects of the biodiesel production process.
Under the terms of the MOU, Advanced Plant Pharmaceuticals, Inc. would acquire World Health Energy, Inc. in return for 20% of APPI. Additionally, APPI would change the name of the company to World Health Energy, Inc. and a new ticker symbol will be applied for in the near future.
David Harel, President of WHE said, "Bio Diesel is a multi-billiondollar industry and World Health Energy is well positioned forthis exciting market. APPI's experience in the development of Whole PlantPharmaceuticals has the potential of identifying opportunities of creatingfeed stock with higher yields resulting in higher profit margins. We arelooking forward to completing the MOU process to add WHE to our company andlaunch our operations into the renewable energy industry."
To be added to APPI's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@advancedplantpharm.com.
About World Health Energy Inc. (www.worldhealthenergy.com)
World Health Energy, Inc. is an emerging renewable energy and biofuel company. The company will produce and market high-quality, low cost B100 Biodiesel to replace traditional fossil fuels.
About Advanced Plant Pharmaceuticals, Inc. (www.advancedplantpharm.com)
Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of whole plant-based nutritionals. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. APPI markets and distributes its line of products including Lo-Chol(tm) worldwide through various sales distribution channels.
"SAFE HARBOR STATEMENT" UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.